Bristol-Myers Squibb to Take Part in Goldman Sachs Health Care Conference June 8 On June 1, 2011 Business News Original Source
Bristol-Myers Squibb to Hold Investor Teleconference to Discuss ASCO Highlights On May 23, 2011 Business News Original Source
ELIQUIS® (apixaban) Approved In Europe For Preventing Venous Thromboembolism After Elective Hip Or Knee Replacement On May 20, 2011 Business News Original Source
New Data from Bristol-Myers Squibb Oncology Portfolio to be Presented at 2011 American Society of Clinical Oncology (ASCO) Annual Meeting On May 20, 2011 Business News Original Source
Bristol-Myers Squibb Invites Public to Listen to Webcast of 2011 Annual Meeting On April 29, 2011 Business News Original Source
Bristol-Myers Squibb Delivers Excellent First Quarter with YERVOY™ (ipilimumab) Approval, Key R&D Milestones and Strong Financials On April 28, 2011 Business News Original Source
Bristol-Myers Squibb to Present at Deutsche Bank Health Care Conference On April 26, 2011 Business News Original Source
New Data on Investigational Agent Belatacept in Kidney Transplant Recipients to be Presented at 2011 American Transplant Congress On April 25, 2011 Business News Original Source
Bristol-Myers Squibb to Announce Results for First Quarter 2011 on April 28 On April 7, 2011 Business News Original Source
Investigational Compound PEG-Interferon Lambda Achieved Higher Response Rates with Fewer Flu-Like and Musculoskeletal Symptoms and Cytopenias Than PEG-Interferon Alfa in Phase IIb Study of 526 Treatment-Naive Hepatitis C Patients On April 2, 2011 Business News Original Source
Investigational Direct-Acting Antiviral BMS-790052 Plus PEG-Interferon Alfa and Ribavirin Achieved Up to 92% Sustained Virologic Response in Phase II Dose-Ranging Study of Treatment-Naïve Hepatitis C Patients On March 31, 2011 Business News Original Source
FDA Approves YERVOY™ (ipilimumab) for the Treatment of Patients with Newly Diagnosed or Previously-Treated Unresectable or Metastatic Melanoma, the Deadliest Form of Skin Cancer On March 25, 2011 Business News Original Source
Phase III Study of Investigational Compound Ipilimumab Achieves Primary Endpoint of Improvement in Overall Survival in Previously-Untreated Patients with Metastatic Melanoma On March 21, 2011 Business News Original Source
Bristol-Myers Squibb Awards Grant to the American College of Physicians Foundation to Address U.S. HIV Medical Workforce Shortage On March 14, 2011 Business News Original Source
Bristol-Myers Squibb Foundation Announces Funding of Nearly $1 Million to Address Needs in Hepatitis B and C Awareness, Prevention and Care in China and India On March 11, 2011 Business News Original Source
Bristol-Myers Squibb to Present at Barclays Capital Global Healthcare Conference On March 9, 2011 Business News Original Source
FDA Accepts New Drug Application for Investigational Compound Dapagliflozin for the Treatment of Type 2 Diabetes On March 8, 2011 Business News Original Source
New Data on Multiple Bristol-Myers Squibb Investigational Hepatitis C Compounds to be Presented at The International Liver Congress 2011 On March 7, 2011 Business News Original Source
Bristol-Myers Squibb and WuXi PharmaTech Announce Collaboration for a New Analytical and Stability Testing Facility On March 7, 2011 Business News Original Source
Business News On July 3, 2022 Chubb Life Appoints Jack Chang to Lead Newly Acquired Life Insurance Operations of Cigna in Taiwan
Business News On July 3, 2022 Chubb Life Appoints Jee Eun Cho to Lead LINA, its Newly Acquired Life Insurance Operations of Cigna in Korea
Business News On July 3, 2022 Chubb Life Announces Gail Costa Will Lead Newly Acquired Life Insurance Operations of Cigna in New Zealand
Business News On July 2, 2022 Northrop Grumman Supports Successful US Space Force-12 Mission from Liftoff to Orbit